Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3).
Stahler A, Heinemann V, Holch JW, von Einem JC, Westphalen CB, Heinrich K, Schlieker L, Jelas I, Alig AHS, Fischer LE, Weiss L, Modest DP, von Weikersthal LF, Decker T, Kiani A, Moehler M, Kaiser F, Kirchner T, Jung A, Stintzing S. Stahler A, et al. Among authors: fischer le. Int J Cancer. 2021 Dec 1;149(11):1935-1943. doi: 10.1002/ijc.33747. Epub 2021 Jul 31. Int J Cancer. 2021. PMID: 34310714
Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy.
Alig AHS, Heinemann V, Geissler M, Fischer von Weikersthal L, Decker T, Heinrich K, Held S, Weiss L, Fischer LE, Moosmann N, Stahler A, Jelas I, Kurreck A, von Einem JC, Reinacher-Schick AC, Tannapfel A, Giessen-Jung C, Stintzing S, Modest DP. Alig AHS, et al. Among authors: fischer le, fischer von weikersthal l. Cancers (Basel). 2022 Jan 21;14(3):526. doi: 10.3390/cancers14030526. Cancers (Basel). 2022. PMID: 35158793 Free PMC article.
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
Fischer LE, Stintzing S, von Weikersthal LF, Modest DP, Decker T, Kiani A, Kaiser F, Al-Batran SE, Heintges T, Lerchenmüller C, Kahl C, Seipelt G, Kullmann F, Stauch M, Scheithauer W, Giessen-Jung C, Uhlig J, Peuser B, Denzlinger C, Stahler A, Weiss L, Heinrich K, Held S, Jung A, Kirchner T, Heinemann V. Fischer LE, et al. Br J Cancer. 2022 Sep;127(5):836-843. doi: 10.1038/s41416-022-01854-y. Epub 2022 May 30. Br J Cancer. 2022. PMID: 35637412 Free PMC article. Clinical Trial.
Liquid Biopsy in Colorectal Cancer: Quo Vadis? Implementation of Liquid Biopsies in Routine Clinical Patient Care in Two German Comprehensive Cancer Centers.
Fischer LE, Stintzing S, Heinemann V, Keilholz U, Keune D, Vollbrecht C, Burmeister T, Kind A, Weiss L, Horst D, Kirchner T, Klauschen F, Jung A, Westphalen CB, Jelas I. Fischer LE, et al. Front Oncol. 2022 May 12;12:870411. doi: 10.3389/fonc.2022.870411. eCollection 2022. Front Oncol. 2022. PMID: 35646657 Free PMC article.
Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy.
Heinrich K, Fischer LE, De Toni EN, Markwardt D, Roessler D, Beyer G, Günther M, Ormanns S, Klauschen F, Kunz WG, Fröhling S, Brummer T, Heinemann V, Westphalen CB. Heinrich K, et al. Among authors: fischer le. JCO Precis Oncol. 2023 Jun;7:e2200650. doi: 10.1200/PO.22.00650. JCO Precis Oncol. 2023. PMID: 37364232 Free PMC article.
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
Weiss L, Heinemann V, Fischer LE, Gieseler F, Hoehler T, Mayerle J, Quietzsch D, Reinacher-Schick A, Schenk M, Seipelt G, Siveke JT, Stahl M, Vehling-Kaiser U, Waldschmidt DT, Dorman K, Zhang D, Westphalen CB, von Bergwelt-Baildon M, Boeck S, Haas M. Weiss L, et al. Among authors: fischer le. Clin Transl Oncol. 2024 May;26(5):1268-1272. doi: 10.1007/s12094-023-03323-1. Epub 2023 Oct 4. Clin Transl Oncol. 2024. PMID: 37794220 Free PMC article.
Development of predictive model for predicting postoperative BMI and optimize bariatric surgery: a single center pilot study.
Ochs V, Tobler A, Wolleb J, Bieder F, Saad B, Enodien B, Fischer LE, Honaker MD, Drews S, Rosenblum I, Stoll R, Probst P, Müller MK, Lavanchy JL, Taha-Mehlitz S, Müller BP, Rosenberg R, Frey DM, Cattin PC, Taha A. Ochs V, et al. Among authors: fischer le. Surg Obes Relat Dis. 2024 Jul 8:S1550-7289(24)00680-4. doi: 10.1016/j.soard.2024.06.012. Online ahead of print. Surg Obes Relat Dis. 2024. PMID: 39117560 Free article.
Global 30-Day Morbidity and Mortality of Primary Bariatric Surgery Combined with Another Procedure: The BLEND Study.
Martinino A, Nanayakkara KDL, Madhok B, Wong GYM, Abouelazayem M, Pereira JPS, Wazir I, Balasubaramaniam V, Said A, Marques C, Abdelbaeth A, Al-Shami K, Albashari M, Alkaseek A, Almayouf MA, Aloulou M, Alqahtan AR, Askari A, Attia MFA, Awad AK, Aykota MR, Bacalbasa N, Barrera-Rodriguez FJ, Benavoli D, Billa S, Borrelli V, Çalıkoğlu İ, Campanelli M, Carbajo MA, Chowdhury S, Cristin L, Dapri G, Dong Z, Elfawal MH, Elgazar A, Elhadi M, Gentileschi P, Graham Y, Haj B, Johnson JA, Kalmoush AM, Kamal A, Kamocka A, Khamees A, Lisi G, Hernandez EEL, Marinari GM, Martines G, Meric S, Mier F, Ali AM, Mohammed D, Mohamed KM, Mulita F, Musella M, O'Malley WE, Olmi S, Omarov T, Osama O, Perera HR, Piscitelli G, Poghosyan T, Ramírez D, Rezvani M, Ribeiro R, Sabbota A, Sakran N, Sawaftah KA, Schiavone K, Şen O, Sotiropoulou M, Tartaglia N, Tokocin M, Trotta M, Türkçapar AG, Uccelli M, Vargas C, Verras G-, Wang C, Wei Z, Yang W, Zerrweck C, Owen E, Gkoutos GV, Cardoso VR, Singhal R, Mahawar K; BLEND Study Collaborative Group. Martinino A, et al. Obes Surg. 2024 Nov;34(11):4152-4165. doi: 10.1007/s11695-024-07296-0. Epub 2024 Jun 13. Obes Surg. 2024. PMID: 38869833
Signature of Altered Retinal Microstructures and Electrophysiology in Schizophrenia Spectrum Disorders Is Associated With Disease Severity and Polygenic Risk.
Boudriot E, Gabriel V, Popovic D, Pingen P, Yakimov V, Papiol S, Roell L, Hasanaj G, Xu S, Moussiopoulou J, Priglinger S, Kern C, Schulte EC, Hasan A, Pogarell O, Falkai P, Schmitt A, Schworm B; CDP Working Group; Wagner E, Keeser D, Raabe FJ. Boudriot E, et al. Biol Psychiatry. 2024 Nov 15;96(10):792-803. doi: 10.1016/j.biopsych.2024.04.014. Epub 2024 Apr 27. Biol Psychiatry. 2024. PMID: 38679358 Free article.
44 results